Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 16/10/2019
SIETES contiene 92824 citas

 
 
 1 a 20 de 426 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. Pfizer to sell generic version of sildenafil. DIA Daily 2017:14. [Ref.ID 102163]
2. Cita con resumen
Anónimo. UK grants sildenafil over-the-counter status. DIA Daily 2017:2. [Ref.ID 102150]
3.Enlace a cita original Cita con resumen
Martinez C, Suissa S, McGill J, Rietbrock S, Katholing A, Freedman B, Cohen AT, Handelsman DJ. Testosterone treatment and risk of venous thromboembolism: population based case-control study. BMJ 2016;355:i5968. [Ref.ID 101016]
5. Cita con resumen
Cunningham GR, Stephens-Shields AJ, Rosen RC, Wang C, Bhasin S, Matsumoto AM, Parsons JK, Gill TM, Molitch ME, Farrar JT, Cella D, Barrett-Connor E, Cauley JA, Cifelli D, Crandall JP, Ensrud KE, Gallagher L, Zeldow B, Lewis CE, Pahor M, Swerdloff RS, Hou X, Anton S, Basaria S, Diem SJ, Tabatabaie V, Ellenberg SS, Snyder PJ. Testosterone treatment and sexual function in older men with low testosterone levels. J Clin Endocrinol Metab 2016;101:3096-104. [Ref.ID 100597]
6.Tiene citas relacionadas Cita con resumen
Messerli FH, Bangalore S, Grossman E. Adverse effects and tolerability of ß blockers. BMJ 2016;353:i3142. [Ref.ID 100378]
7. Cita con resumen
Anónimo. FDA warns about several safety issues with opioid pain medicines; requires label changes. U.S. Food and Drug Administration 2016:22 de marzo. [Ref.ID 100078]
8. Cita con resumen
Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, Gill TM, Barrett-Connor E, Swerdloff RS, Wang C, Ensrud KE, Lewis CE, Farrar JT, Cella D, Rosen RC, Pahor M, Crandall JP, Molitch ME, Cifelli D, Dougar D, Fluharty L, Resnick SM, Storer TW, Anton S, Basaria S, Diem SJ, Hou X, Mohler ER, Parsons JK, Wenger NK, Zeldow B, Landis JR, Ellenberg SS, for the Testosterone Trials Investigators. Effects of testosterone treatment in older men. N Engl J Med 2016;374:611-24. [Ref.ID 100026]
9. Cita con resumen
Loeb S, Folkvaljon Y, Lambe M, Robinson D, Gamo H, Ingvar C, Stattin P. Use of phosphodiesterase type 5 inhibitors for erectile dysfunction and risk of malignant melanoma. JAMA 2015;313:2449-55. [Ref.ID 99307]
10. Cita con resumen
Anónimo. Avanafil (Stendra) - Another PDE5 inhibitor for erectile dysfunction. Med Lett Drugs Ther 2014;56:37-8. [Ref.ID 97619]
11. Cita con resumen
Anónimo. Dapoxetine for premature ejaculation. Drug Ther Bull 2014;52:30-3. [Ref.ID 97226]
12. Cita con resumen
Muneer A, Kalsi J, Nazareth I, Arya M. Erectile dysfunction. BMJ 2014;348:g129. [Ref.ID 97218]
13. Cita con resumen
14. Cita con resumen
Anónimo. Tadalafil (Cialis) et hypertrophie bénigne de la prostate. Prescrire 2013;33:886-7. [Ref.ID 96715]
16. Cita con resumen
Montastruc J-L. Médicaments et drogues à l'origine de dysfonctions érectiles. Bulletin d'Informations de Pharmacologie 2013;20:2. [Ref.ID 95184]
17.
Shamloul R, Ghanem H. Erectile dysfunction. Lancet 2013;381:153-65. [Ref.ID 94768]
18. Cita con resumen
Spitzer M, Basaria S, Travison TG, Davda MN, Paley A, Cohen B, Mazer MA, Knapp PE, Hanka S, Lakshman KM, Ulloor J, Zhang A, Orwoll K, Eder R, Collins L, Mohammed N, Rosen RC, DeRogatis L, Shasin S. Effect of testosterone replacement on response to sildenafil citrate in men with erectible dysfunction: a parallel, randomized trial. Ann Intern Med 2012;157:681-91. [Ref.ID 94088]
19. Cita con resumen
Seleccionar todas
 
 1 a 20 de 426 siguiente >>